Fundraising Fox
Biosapien
Founded 2018 · 9 employees on LinkedIn · 6 known investors
Find your way into Biosapien
Sign up to see every warm intro you have to Biosapien
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biosapien team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
Investors · 6
Beni Venture Capitallisted by Beni Venture CapitalMiami · $100K – $250K
How we know: Beni Venture Capital's portfolio page · Not right? Tell us
Global Ventureslisted by Global VenturesDubai · $1M – $3M
How we know: Global Ventures's portfolio page · entarabi.com · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 1
Dara Holdings
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Series AJan 2025
Global Ventures (lead), Dara Holdings, Golden Gate Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 3
Predictive OncologyPredictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
ClementiaIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
Companies working in the same space as Biosapien.
Frequently asked questions
- What does Biosapien do?
- Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
- Who are Biosapien's investors?
- Biosapien's investors include Beni Venture Capital, Global Ventures, Globivest, Golden Gate Ventures, SOSV.